Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Accord-UK Ltd, Whiddon Valley, Barnstaple, Devon, EX32 8NS
Repaglinide 0.5 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Repaglinde 0.5 mg Tablets are white, round, biconvex and engraved with RE on one side. |
Each tablet contains 0.5 mg of repaglinide.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Repaglinide |
Repaglinide is a short-acting oral secretagogue. Repaglinide lowers the blood glucose levels acutely by stimulating the release of insulin from the pancreas, an effect dependent upon functioning β-cells in the pancreatic islets. |
| List of Excipients |
|---|
|
Microcrystalline cellulose (E460) |
Blisters (Aluminium/Aluminium).
Pack sizes: 30, 60, 90, 100, 120 and 180 tablets
Plastic (polyethylene) container with desiccant canister (filled with silica gel).
Pack sizes: 100 tablets
Not all pack sizes may be marketed.
Accord-UK Ltd, Whiddon Valley, Barnstaple, Devon, EX32 8NS
PL 0142/1010
09/04/2010
05/11/2015
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
